Stocks / NYSE / Glaukos Corporation

Glaukos Corporation

Company Description

Glaukos Corp. is an ophthalmic medical device company, which engages in the development and commercialization of products and procedures designed to transform the treatment of glaucoma. Its micro invasive glaucoma surgery procedures are designed to reduce intraocular eye pressure by improving aqueous outflow through the natural physiologic pathway. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill in July 1998 and is headquartered in San Clemente, CA. [Source: MarketWatch]

Company Website: